Skip to content
Open access

Advancements and prospects in bioinformatics and omics for colorectal cancer: A dual bibliometric analysis of global trends and top cited publications

Sep 2026 · Journal of Intelligent Medicine · 0 citations · 35 references

TL;DR

The research progress of CRC heterogeneity is summarized, the development direction of multiomics integration and combination with artificial intelligence technology is outlined, and the research hotspots of immunotherapy and the tumor microenvironment are explored.

Abstract

Bioinformatics and omics have been extensively applied in colorectal cancer (CRC) research, contributing to significant scientific advances. We conducted a dual bibliometric analysis integrating overall trends with influential literature to identify major developments and emerging directions in the field. This study retrieved bioinformatics and omics‐related articles in the field of CRC from the Web of Science Core Collection from 2004 to 2025 and the top 100 most cited publications. Using SCImago Graphica, VOSviewer, CiteSpace, and RStudio, we analyzed and visualized data on countries/regions, institutions, journals, authors, citations, references, and keywords. After restriction and manual screening, 5129 publications met our criteria. The publication output has steadily increased. China and the USA led in output, international collaboration, and institutional contributions. Keyword clustering and burst analyses highlight advancements and prospects, with burst detection indicating that topics related to machine learning and immunotherapy are emerging as key research areas. We conducted a dual bibliometric analysis of bioinformatics and omics in CRC. This study summarized the research progress of CRC heterogeneity, outlined the development direction of multiomics integration and combination with artificial intelligence technology, and explored the research hotspots of immunotherapy and the tumor microenvironment.

Read PDF

Similar papers

Review Open access Aug 2026

Bibliometric analysis of research on liver cancer and single‑cell RNA sequencing: evolutionary trends, opportunities, and future perspectives

This bibliometric analysis systematically maps the evolving research landscape of single-cell RNA sequencing (scRNA-seq) in liver cancer (LC). It summarizes global publication trends, identifies key contributors and collaborative networks, and trace the development of research hotspots over time. Publications related t...

Yi Zheng, Qian-rong Wang, Qiong Zhang et al. · 1 citation
Review Sep 2026

Global trends and hotspots in bladder cancer: A bibliometric analysis (2016-2025).

INTRODUCTION Bladder cancer research has experienced a rapid increase in publication output with the emergence of new themes in diagnosis and treatment. The expanding literature makes it challenging to identify overarching trends and key developments. Therefore, a bibliometric analysis is warranted to systematically ev...

R. Heer, M. Farrokhi · 0 citations
Review Open access Sep 2026

Global trends and emerging frontiers in cancer immunotherapy and gut microbiota-derived metabolites: a bibliometric analysis

Objectives Cancer immunotherapy has achieved remarkable clinical success; however, therapeutic resistance remains a major challenge. Increasing evidence suggests that gut microbiota-derived metabolites play a critical role in modulating host immune responses and influencing treatment outcomes. This study aimed to syste...

Ying-Ying Hu, Chen-Huai Teng, Dian Zhang · 0 citations
Review Open access Sep 2026

Bibliometric Analysis of Gut Microbiota and Hepatocellular Carcinoma: Research Trends and Frontiers

The field shows rapid expansion with a China–USA dual research high-output research pattern, shifting toward microbial metabolites and microbiota-targeted immunotherapy, and future advances rely on causal mechanism verification, large-scale clinical trials and strengthened international collaboration.

Cheng-Pu Zhao, Xiang-Chen Hu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.